3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
6
Leukemia, Myeloid, Acute
4
Uveal Melanoma
2
Lymphoma
2
Leukemia
2
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Select Advanced Solid Tumors
1
Recurrence
1
Rectal Neoplasms
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Pleural Effusion, Malignant
1
Pancreatic Neoplasms
1
Neuroblastoma
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Meningeal Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Leukemia, Myeloid
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Kidney Neoplasms
1
Kidney Diseases
1
Gastrointestinal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Interventions
Temozolomide
7
Vincristine
5
Cyclophosphamide
5
X-Rays
4
Specimen Handling
4
Phantoms, Imaging
4
Magnetic Resonance Spectroscopy
4
Irinotecan
4
cabozantinib
3
Ifosfamide
3
Etoposide
3
Doxorubicin
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
liposomal doxorubicin
2
ivosidenib
2
fludarabine
2
Topotecan
2
Radiation
2
Nuclear Medicine Department, Hospital
2
LY3023414
2
Eflornithine
2
Congresses as Topic
2
trifluridine tipiracil drug combination
1
talazoparib
1
silmitasertib
1
romiplostim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma, Ewing
×
Interleukin-2
×
90 days
×
Clear all
No trials found.